Posts Tagged ‘mild-cognitive-impairment’
Six guidelines to navigate the Aduhelm controversy and (hopefully) help patients with Mild Cognitive Impairment and early-stage Alzheimer’s Disease
The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging. After initially indicating that Aduhelm could be prescribed to anyone with dementia, the Food and Drug Administration now specifies that…
Read MoreOn cognitive reframing and biases, stress, mental health tech, Aduhelm backlash, Britney Spears, and more
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring this time nine scientific reports and industry developments to help promote lifelong brain and mental health. #1. To lower stress levels and improve problem-solving, practice cognitive reframing instead of venting “… venting likely doesn’t soothe anger as much as augment it. That’s because encouraging people to…
Read MoreVeterans Affairs won’t cover Biogen’s new “Alzheimer’s drug” given concerns over safety and lack of evidence
VA Health System Won’t Cover Biogen’s Alzheimer’s Drug (The Wall Street Journal): The Department of Veterans Affairs won’t cover Biogen Inc.’s new Alzheimer’s drug, the latest rebuke of the controversial treatment since it was approved earlier this summer. The VA decided not add the drug, called Aduhelm, to its formulary list of available medicines because…
Read MoreThe new frontier in neurocognitive monitoring and dementia screening: the Apple Watch
Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone (press release): Biogen Inc. (Nasdaq: BIIB) today announced a new virtual research study, in collaboration with Apple, to investigate the role Apple Watch and iPhone could play in monitoring cognitive performance and screening for decline in cognitive health…
Read MoreStudy: Actual, sustained practice–not mere knowledge–is needed to harness neuroplasticity and improve cognition over time
Lifestyle improvements may lessen cognitive decline (Wiley): ” … 19 individuals older than 65 years of age who were experiencing cognitive decline were randomized to a control group or an intervention group for 8 weeks. The control group received online information related to dementia and lifestyle risk factors, Mediterranean diet, physical activity, and cognitive engagement.…
Read MoreAnticholinergic drugs found to significantly increase risk of cognitive decline, especially among those with Alzheimer’s Disease biomarkers or genetic predisposition
Common Class of Drugs Linked to Increased Risk of Alzheimer’s Disease (UC San Diego release): A team of scientists, led by researchers at University of California San Diego School of Medicine, report that a class of drugs used for a broad array of conditions, from allergies and colds to hypertension and urinary incontinence, may be…
Read More